Wave Life Sciences (WVE) EBIT Margin (2016 - 2025)
Wave Life Sciences (WVE) has disclosed EBIT Margin for 11 consecutive years, with 606.49% as the latest value for Q2 2025.
- For the quarter ending Q2 2025, EBIT Margin fell 42877.0% year-over-year to 606.49%, compared with a TTM value of 1205.01% through Dec 2025, down 86246.0%, and an annual FY2025 reading of 504.09%, down 40215.0% over the prior year.
- EBIT Margin was 606.49% for Q2 2025 at Wave Life Sciences, down from 542.82% in the prior quarter.
- Across five years, EBIT Margin topped out at 9.03% in Q3 2023 and bottomed at 13648.77% in Q3 2022.
- Average EBIT Margin over 5 years is 2405.62%, with a median of 542.82% recorded in 2025.
- The sharpest move saw EBIT Margin plummeted -1362789bps in 2022, then soared 1365780bps in 2023.
- Year by year, EBIT Margin stood at 2045.89% in 2021, then tumbled by -72bps to 3515.98% in 2022, then soared by 98bps to 64.3% in 2023, then crashed by -176bps to 177.72% in 2024, then crashed by -241bps to 606.49% in 2025.
- Business Quant data shows EBIT Margin for WVE at 606.49% in Q2 2025, 542.82% in Q1 2025, and 177.72% in Q2 2024.